Single-dose NEPA versus 3-day aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with risk factors receiving moderately emetogenic chemotherapy (MEC) - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Annals of Oncology Année : 2021

Single-dose NEPA versus 3-day aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with risk factors receiving moderately emetogenic chemotherapy (MEC)

(1) , , , , (2) , (3) , (4, 5) , (6) , (7) , , , ,
1
2
3
4
5
6
7

Dates et versions

hal-03598658 , version 1 (05-03-2022)

Identifiants

Citer

L. Zelek, P. Debourdeau, H. Bourgeois, J. P. Wagner, F. Brocard, et al.. Single-dose NEPA versus 3-day aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with risk factors receiving moderately emetogenic chemotherapy (MEC). Annals of Oncology, 2021, 32 (5), pp.S1175. ⟨10.1016/j.annonc.2021.08.1644⟩. ⟨hal-03598658⟩
13 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More